⌘K
Loading ticker…
As of 2026-08-24, Revolution Medicines, Inc. Common Stock (RVMD) has a 3-month relative strength percentile of 91 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 92. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.8%, relative volume 0.94×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
RVMD is in a stage 2 uptrend, week 12. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 12.4% / 66.0%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
RVMD is held by 38 ETFs as of May 2026. Top owner: SCHA at 0.65% weight, $148M notional. Top 3 carry $309M.
Held by 111 ETFs · $2.5B across latest filings · largest weight 7.73% (CANC).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.65% | $148M | +0.22 pp |
| SCHMSchwab U.S. Mid-Cap ETF | 0.57% | $84M | +0.21 pp |
| VHTVanguard Health Care ETF | 0.40% | $76M | +0.19 pp |
| CGMM | 0.67% | $19M | new |
| SCHBSchwab U.S. Broad Market ETF |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.04% |
| $18M |
| +0.01 pp |
| VONVVanguard Russell 1000 Value ETF | 0.08% | $18M | +0.03 pp |
| QQQJ | 1.45% | $16M | +0.48 pp |
| CANC | 7.73% | $14M | +1.44 pp |
| GVIP | 2.06% | $12M | new |
| GSLC | 0.07% | $11M | new |
Showing 10 of 38 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RVMD Jan avg: 7.23% median: 5.23% win: 50% σ: 11.92% n: 4 2022-04-12 → 2026-07-31 | RVMD Feb avg: 1.60% median: 2.65% win: 75% σ: 5.24% n: 4 2022-04-12 → 2026-07-31 | RVMD Mar avg: -6.90% median: -8.94% win: 25% σ: 12.33% n: 4 2022-04-12 → 2026-07-31 | RVMD Apr avg: 14.26% median: 14.20% win: 80% σ: 22.67% n: 5 2022-04-12 → 2026-07-31 | RVMD May avg: 0.16% median: 2.82% win: 60% σ: 9.50% n: 5 2022-04-12 → 2026-07-31 | RVMD Jun avg: 7.13% median: 7.30% win: 80% σ: 10.26% n: 5 2022-04-12 → 2026-07-31 | RVMD Jul avg: 6.62% median: 1.31% win: 80% σ: 9.34% n: 5 2022-04-12 → 2026-07-31 | RVMD Aug avg: 4.23% median: -2.36% win: 50% σ: 17.33% n: 4 2022-04-12 → 2026-07-31 (current) | RVMD Sep avg: 1.38% median: 0.53% win: 50% σ: 17.64% n: 4 2022-04-12 → 2026-07-31 | RVMD Oct avg: 4.56% median: 10.36% win: 75% σ: 24.04% n: 4 2022-04-12 → 2026-07-31 | RVMD Nov avg: 18.64% median: 17.13% win: 100% σ: 9.98% n: 4 2022-04-12 → 2026-07-31 | RVMD Dec avg: 0.49% median: 1.70% win: 75% σ: 19.38% n: 4 2022-04-12 → 2026-07-31 |